(Q73345148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Realizing the promise of apoptosis-based therapies: separating the living from the clinically undead (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401217

30 December 2023

author name string

J. L. Tilly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12728247

30 December 2023

R. N. Kolesnick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12728247

30 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12728247

30 December 2023

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

http://www.nature.com/articles/4401217

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.CDD.4401217

http://www.nature.com/articles/4401217.pdf

30 December 2023

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.CDD.4401217

Cell Death & Differentiation

30 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

493-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

From bench to clinic with apoptosis-based therapeutic agents

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Multiple late complications of therapy with cyclophosphamide, including ovarian destruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Sterility and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Regulation of ceramide production and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

The therapeutic potential of modulating the ceramide/sphingomyelin pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Sphingosine 1-phosphate as a therapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401217

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12728247%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference